The molecular genetics of Usher syndrome

Clinical Genetics

Volumn 63, Issue 6, 2003, Pages 431-444

  Ahmed, Z M ^a,b   Riazuddin, S ^a,b   Wilcox, Edward R ^a,b  

^a UNIVERSITY OF THE PUNJAB   (Pakistan)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

Deafness; Retinitis pigmentosa; Usher syndrome; Vestibular dysfunction

Indexed keywords

CADHERIN; MYOSIN;

CELL FUNCTION; CELL TYPE; CHROMOSOMAL LOCALIZATION; CHROMOSOME MAP; COCHLEA; DISEASE CLASSIFICATION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; INNER EAR; MOLECULAR CLONING; MOLECULAR GENETICS; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROTEIN INTERACTION; RETINA CELL; RETINITIS PIGMENTOSA; REVIEW; STEREOCILIUM; USHER SYNDROME; VESTIBULAR DISORDER;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; HEARING LOSS, SENSORINEURAL; HUMANS; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; RETINITIS PIGMENTOSA; VESTIBULE;

EID: 0043244878     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.00109.x     Document Type: Review

References (111)

1. Admiraal RJ, Huygen PL. Changes in the aetiology of hearing impairment in deaf-blind pupils and deaf infant pupils at an institute for the deaf. Int J Pediatr Otorhinolaryngol 2000: 55: 133-142.
2. Armitage IM, Burke JP, Buffin JT. Visual impairment in severe and profound sensorineural deafness. Arch Dis Child 1995: 73: 53-56.
3. Nicoll AM, House P. Ocular abnormalities in deaf children a discussion of deafness and retinal pigment changes. Aust N Z J Ophthalmol 1988: 16: 205-208.
4. VonGraefe A. Exceptionelles Verhalten des Gesichtsfeldes bei Pigmententartung der Netzhaut. Archiv für Ophthalmologie 1858: 4: 250-253.
5. Kloepfer HW, Laguaite JK. The hereditary syndrome of congenital deafness and retinitis pigmentosa. (Usher's syndrome). Laryngoscope 1966: 76: 850-862.
6. Rosenberg T, Haim M, Hauch AM et al. The prevalence of Usher syndrome and other retinal dystrophy-hearing impairment associations. Clin Genet 1997: 51: 314-321.
7. Boughman JA, Vernon M, Shaver KA. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis 1983: 36: 595-603.
8. Haim M. Prevalence of retinitis pigmentosa and allied disorders in Denmark. II. Systemic involvement and age at onset. Acta Ophthalmol (Copenh) 1992: 70: 417-426.
9. Hope CI, Bundey S, Proops D et al. Usher syndrome in the city of Birmingham - prevalence and clinical classification. Br J Ophthalmol 1997: 81: 46-53.
10. Boughman JA, Conneally PM, Nance WE. Population genetic studies of retinitis pigmentosa. Am J Hum Genet 1980: 32: 223-235.
11. Haim M. Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scand 2002: 80 (Suppl. 233): 1-34.
12. Fortnum HM, Summerfield AQ, Marshall DH et al. Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study. BMJ 2001: 323: 536-540.
13. Fortnum HM, Marshall DH, Summerfield AQ. Epidemiology of the UK population of hearing-impaired children, including characteristics of those with and without cochlear implants - audiology, aetiology, comorbidity and affluence. Int J Audiol 2002: 41: 170-179.
14. Marazita ML, Ploughman LM, Rawlings B et al. Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet 1993: 46: 486-491.
15. Smith RJ, Berlin CI, Hejtmancik JF et al. Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. Am J Med Genet 1994: 50: 32-38.
16. Tsilou ET, Rubin BI, Caruso RC et al. Usher syndrome clinical types I and II: could ocular symptoms and signs differentiate between the two types? Acta Ophthalmol Scand 2002: 80: 196-201.
17. Wagenaar M, van Aarem A, Huygen P et al. Hearing impairment related to age in Usher syndrome types 1B and 2A. Arch Otolaryngol Head Neck Surg 1999: 125: 441-445.
18. Sankila EM, Pakarinen L, Kaariainen H et al. Assignment of an Usher syndrome type III (USH3) gene to chromosome 3q. Hum Mol Genet 1995: 4: 93-98.
19. Otterstedde CR, Spandau U, Blankenagel A et al. A new clinical classification for Usher's syndrome based on a new subtype of Usher's syndrome type I. Laryngoscope 2001: 111: 84-86.
20. Kimberling WJ, Weston MD, Moller C et al. Localization of Usher syndrome type II to chromosome 1q. Genomics 1990: 7: 245-249.
21. Lewis RA, Otterud B, Stauffer D et al. Mapping recessive ophthalmic diseases: linkage of the locus for Usher syndrome type II to a DNA marker on chromosome 1q. Genomics 1990: 7: 250-256.
22. Kimberling WJ, Moller CG, Davenport S et al. Linkage of Usher syndrome type I gene (USH1B) to the long arm of chromosome 11. Genomics 1992: 14: 988-994.
23. Smith RJ, Lee EC, Kimberling WJ et al. Localization of two genes for Usher syndrome type I to chromosome 11. Genomics 1992: 14: 995-1002.
24. Keats BJ, Nouri N, Pelias MZ et al. Tightly linked flanking microsatellite markers for the Usher syndrome type I locus on the short arm of chromosome 11. Am J Hum Genet 1994: 54: 681-686.
25. Friedman T, Battey J, Kachar B et al. Modifier genes of hereditary hearing loss. Curr Opin Neurobiol 2000: 10: 487-493.
26. Wayne S, Der Kaloustian VM, Schloss M et al. Localization of the Usher syndrome type ID gene (Ush1D) to chromosome 10. Hum Mol Genet 1996: 5: 1689-1692.
27. Wayne S, Lowry RB, McLeod DR et al. Localization of the Usher syndrome type IF (Ush1F) to chromosome 10. Am J Hum Genet 1997: 61: (Abstract) 1752.
28. Mustapha M, Chouery E, Torchard-Pagnez D et al. A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24-25. Hum Genet 2002: 110: 348-350.
29. Hmani M, Ghorbel A, Boulila-Elgaied A et al. A novel locus for Usher syndrome type II, USH2B, maps to chromosome 3 at p23-24.2. Eur J Hum Genet 1999: 7: 363-367.
30. Weil D, Blanchard S, Kaplan J et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995: 374: 60-61.
31. Bitner-Glindzicz M, Lindley KJ, Rutland P et al. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet 2000: 26: 56-60.
32. Verpy E, Leibovici M, Zwaenepoel I et al. A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat Genet 2000: 26: 51-55.
33. Bolz H, von Brederlow B, Ramirez A et al. Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat Genet 2001: 27: 108-112.
34. Bork JM, Peters LM, Riazuddin S et al. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet 2001: 68: 26-37.
35. Ahmed ZM, Riazuddin S, Bernstein SL et al. Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. Am J Hum Genet 2001: 69: 25-34.
36. Alagramam KN, Yuan H, Kuehn MH et al. Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet 2001: 10: 1709-1718.
37. Weil D, El-Amraoui A, Masmoudi S et al. Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin. Hum Mol Genet 2003: 12: 463-471.
38. Eudy JD, Weston MD, Yao S et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 1998: 280: 1753-1757.
39. Joensuu T, Hamalainen R, Yuan B et al. Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am J Hum Genet 2001: 69: 673-684.
40. Adato A, Vreugde S, Joensuu T et al. USH3A transcripts encode clarin-1, a four-transmembrane-domain protein with a possible role in sensory synapses. Eur J Hum Genet 2002: 10: 339-350.
41. Fields RR, Zhou G, Huang D et al. Usher syndrome type III. revised genomic structure of the USH3 gene and identification of novel mutations. Am J Hum Genet 2002: 71: 607-617.
42. Hereditary Hearing Loss Homepage. http://dnalab-www.uia.ac.be/dnalab/hhh/.
43. Chaib H, Place C, Salem N et al. Mapping of DFNB12, a gene for a non-syndromal autosomal recessive deafness, to chromosome 10q21-22. Hum Mol Genet 1996: 5: 1061-1064.
44. Jain PK, Lalwani AK, Li XC et al. A gene for recessive nonsyndromic sensorineural deafness (DFNB18) maps to the chromosomal region 11p14-p15.1 containing the Usher syndrome type 1C gene. Genomics 1998: 50: 290-292.
45. Fukushima K, Ramesh A, Srisailapathy CR et al. An autosomal recessive nonsyndromic form of sensorineural hearing loss maps to 3p-DFNB6. Genome Res 1995: 5: 305-308.
46. Rivolta C, Sweklo EA, Berson EL et al. Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss. Am J Hum Genet 2000: 66: 1975-1978.
47. Astuto LM, Bork JM, Weston MD et al. CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet 2002: 71: 262-275.
48. Liu XZ, Walsh J, Tamagawa Y et al. Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet 1997: 17: 268-269.
49. Liu XZ, Hope C, Walsh J et al. Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet 1998: 63: 909-912.
50. Astuto LM, Weston MD, Carney CA et al. Genetic heterogeneity of Usher syndrome: analysis of 151 families with Usher type I. Am J Hum Genet 2000: 67: 1569-1574.
51. Guilford P, Ayadi H, Blanchard S et al. A human gene responsible for neurosensory, non-syndromic recessive deafness is a candidate homologue of the mouse sh-1 gene. Hum Mol Genet 1994: 3: 989-993.
52. Zina ZB, Masmoudi S, Ayadi H et al. From DFNB2 to Usher syndrome: variable expressivity of the same disease. Am J Med Genet 2001: 101: 181-183.
53. Astuto LM, Kelley PM, Askew JW et al. Searching for evidence of DFNB2. Am J Med Genet 2002: 109: 291-297.
54. Tamagawa Y, Kitamura K, Ishida T et al. A gene for a dominant form of non-syndromic sensorineural deafness (DFNA11) maps within the region containing the DFNB2 recessive deafness gene. Hum Mol Genet 1996: 5: 849-852.
55. Brown SD, Brown KA, Sutcliffe MJ et al. Reverse genetic approaches to cloning deafness genes. Ann N Y Acad Sci 1991: 630: 93-99.
56. Gibson F, Walsh J, Mburu P et al. A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 1995: 374: 62-64.
57. Liu XZ, Walsh J, Mburu P et al. Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet 1997: 16: 188-190.
58. Weil D, Kussel P, Blanchard S et al. The autosomal recessive isolated deafness, DFNB2, and the Usher 1B syndrome are allelic defects of the myosin-VIIA gene. Nat Genet 1997: 16: 191-193.
59. Friedman TB, Sellers JR, Avraham KB. Unconventional myosins and the genetics of hearing loss. Am J Med Genet 1999: 89: 147-157.
60. Weston MD, Kelley PM, Overbeck LD et al. Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients. Am J Hum Genet 1996: 59: 1074-1083.
61. Mermall V, Post PL, Mooseker MS. Unconventional myosins in cell movement, membrane traffic, and signal transduction. Science 1998: 279: 527-533.
62. Adato A, Weil D, Kalinski H et al. Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins. Am J Hum Genet 1997: 61: 813-821.
63. Chen ZY, Hasson T, Kelley PM et al. Molecular cloning and domain structure of human myosin-VIIa, the gene product defective in Usher syndrome 1B. Genomics 1996: 36: 440-448.
64. Petit C. Usher syndrome: from genetics to pathogenesis. Annu Rev Genomics Hum Genet 2001: 2: 271-297.
65. Libby RT, Steel KP. The roles of unconventional myosins in hearing and deafness. Essays Biochem 2000: 35: 159-174.
66. Scanlan MJ, Williamson B, Jungbluth A et al. Isoforms of the human PDZ-73 protein exhibit differential tissue expression. Biochim Biophys Acta 1999: 1445: 39-52.
67. Ahmed ZM, Smith TN, Riazuddin S et al. Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USH1C. Hum Genet 2002: 110: 527-531.
68. Ouyang XM, Xia XJ, Verpy E et al. Mutations in the alternatively spliced exons of USH1C cause non-syndromic recessive deafness. Hum Genet 2002: 111: 26-30.
69. Boeda B, El-Amraoui A, Bahloul A et al. Myosin VIIa, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle. EMBO J 2002: 21: 6689-6699.
70. Sheng M, Sala C. PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci 2001: 24: 1-29.
71. Fanning AS, Anderson JM. Protein modules as organizers of membrane structure. Curr Opin Cell Biol 1999: 11: 432-439.
72. Fanning AS, Anderson JM. PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 1999: 103: 767-772.
73. Siemens J, Kazmierczak P, Reynolds A et al. The Usher syndrome proteins cadherin 23 and harmonin form a complex by means of PDZ-domain interactions. Proc Natl Acad Sci USA 2002: 99: 14946-14951.
74. Di Palma F, Holme RH, Bryda EC et al. Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1D. Nat Genet 2001: 27: 103-107.
75. Johnson KR, Erway LC, Cook SA et al. A major gene affecting age-related hearing loss in C57BL/6J mice. Hear Res 1997: 114: 83-92.
76. Noben-Trauth K, Zheng QY, Johnson KR et al. mdfw: a deafness susceptibility locus that interacts with deaf waddler (dfw). Genomics 1997: 44: 266-272.
77. Bryda EC, Kim HJ, Legare ME et al. High-resolution genetic and physical mapping of modifier-of-deafwaddler (mdfw) and Waltzer (Cdh23v). Genomics 2001: 73: 338-342.
78. Boggon TJ, Murray J, Chappuis-Flament S et al. C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science 2002: 296: 1308-1313.
79. Alagramam KN, Murcia CL, Kwon HY et al. The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene. Nat Genet 2001: 27: 99-102.
80. Murcia CL, Woychik RP. Expression of Pcdh15 in the inner ear, nervous system and various epithelia of the developing embryo. Mech Dev 2001: 105: 163-166.
81. Raphael Y, Kobayashi KN, Dootz GA et al. Severe vestibular and auditory impairment in three alleles of Ames waltzer (av) mice. Hear Res 2001: 151: 237-249.
82. Kikkawa Y, Shitara H, Wakana S et al. Mutations in a new scaffold protein Sans cause deafness in Jackson shaker mice. Hum Mol Genet 2003: 12: 453-461.
83. Sumegi J, Wang JY, Zhen DK et al. The construction of a yeast artificial chromosome (YAC) contig in the vicinity of the Usher syndrome type IIa (USH2A) gene in 1q41. Genomics 1996: 35: 79-86.
84. Kimberling WJ, Weston MD, Moller C et al. Gene mapping of Usher syndrome type IIa: localization of the gene to a 2.1-cM segment on chromosome 1q41. Am J Hum Genet 1995: 56: 216-223.
85. Weston MD, Eudy JD, Fujita S et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet 2000: 66: 1199-1210.
86. Bhattacharya G, Miller C, Kimberling WJ et al. Localization and expression of usherin: a novel basement membrane protein defective in people with Usher's syndrome type IIa. Hear Res 2002: 163: 1-11.
87. Dreyer B, Tranebjaerg L, Brox V et al. A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet 2001: 69: 228-234.
88. Liu XZ, Hope C, Liang CY et al. A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. Am J Hum Genet 1999: 64: 1221-1225.
89. Joensuu T, Blanco G, Pakarinen L et al. Refined mapping of the Usher syndrome type III locus on chromosome 3, exclusion of candidate genes, and identification of the putative mouse homologous region. Genomics 1996: 38: 255-263.
90. Joensuu T, Hamalainen R, Lehesjoki AE et al. A sequence-ready map of the Usher syndrome type III critical region on chromosome 3q. Genomics 2000: 63: 409-416.
91. Adato A, Kalinski H, Weil D et al. Possible interaction between USH1B and USH3 gene products as implied by apparent digenic deafness inheritance. Am J Hum Genet 1999: 65: 261-265.
92. Espinos C, Millan JM. Investigacion genetica sobre el sindrome de Usher en Espana. [Genetic research on Usher's syndrome in Spain]. Med Clin (Barc) 1998: 110: 340-341.
93. Gasparini P, De Fazio A, Croce AI et al. Usher syndrome type III (USH3) linked to chromosome 3q in an Italian family. J Med Genet 1998: 35: 666-667.
94. Fields RR, Kimberling WJ, Cosgrove DE. Localization and developmental expression of the protein encoded for by the Usher syndrome III gene. Assoc Res Otolaryngol 2003: (abstract) 1047, http://www.aro.org/.
95. Kaplan J, Gerber S, Bonneau D et al. A gene for Usher syndrome type I (USH1A) maps to chromosome 14q. Genomics 1992: 14: 979-987.
96. Chaib H, Kaplan J, Gerber S et al. A newly identified locus for Usher syndrome type I, USH1E, maps to chromosome 21q21. Hum Mol Genet 1997: 6: 27-31.
97. Liu XZ, Newton VE, Steel KP et al. Identification of a new mutation of the myosin VII head region in Usher syndrome type 1. Hum Mutat 1997: 10: 168-170.
98. Janecke AR, Meins M, Sadeghi M et al. Twelve novel myosin VIIA mutations in 34 patients with Usher syndrome type I. confirmation of genetic heterogeneity. Hum Mutat 1999: 13: 133-140.
99. Bharadwaj AK, Kasztejna JP, Huq S et al. Evaluation of the myosin VIIA gene and visual function in patients with Usher syndrome type I. Exp Eye Res 2000: 71: 173-181.
100. Mena A, Camara J, Vieira H et al. New mutations in myosin VIIa gene in the Portuguese population. Am J Hum Genet 2000: 67 (4, Suppl.): (abstract) 2263.
101. Weston MD, Carney CA, Rivedal SA et al. Spectrum of myosin VIIA mutations causing Usher syndrome type 1b. Assoc Res Otolaryngol 1998: (abstract) 181, http://www.aro.org/.
102. Levy G, Levi-Acobas F, Blanchard S et al. Myosin VIIA gene: heterogeneity of the mutations responsible for Usher syndrome type IB. Hum Mol Genet 1997: 6: 111-116.
103. Cuevas JM, Espin SC, Millan JM et al. Identification of three novel mutations in the MYO7A gene. Hum Mutat 1999: 14: 181.
104. Zwaenepoel I, Verpy E, Blanchard S et al. Identification of three novel mutations in the USH1C gene and detection of thirty-one polymorphisms used for haplotype analysis. Hum Mutat 2001: 17: 34-41.
105. de Brouwer AP, Pennings RJ, Roeters M et al. Mutations in the calcium-binding motifs of CDH23 and the 35delG mutation in GJB2 cause hearing loss in one family. Hum Genet 2003: 112: 156-163.
106. von Brederlow B, Bolz H, Janecke A et al. Identification and in vitro expression of novel CDH23 mutations of patients with Usher syndrome type 1D. Hum Mutat 2002: 19: 268-273.
107. Dreyer B, Tranebjaerg L, Rosenberg T et al. Identification of novel USH2A mutations: implications for the structure of USH2A protein. Eur J Hum Genet 2000: 8: 500-506.
108. Adato A, Weston MD, Berry A et al. Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families. Hum Mutat 2000: 15: 388.
109. Leroy BP, Aragon-Martin JA, Weston MD et al. Spectrum of mutations in USU2A in British patients with Usher syndrome type II. Exp Eye Res 2001: 72: 503-509.
110. Pieke-Dahl S, Moller CG, Kelley PM et al. Genetic heterogeneity of Usher syndrome type II. localization to chromosome 5q. J Med Genet 2000: 37: 256-262.
111. Ben-Yosef T, Ness SL, Madeo AC et al. A prevalent mutation of PCDH15 among Ashkenazi, Jews with the type 1 Usher syndrome. N Engl J Med 2003: 348: 1664-1670.